The Tay-Sachs Disease Market is estimated at US$3.1 billion in 2026 and is projected to grow at a CAGR of 5.9% to reach US$4.9 billion by 2034.
Its value chain includes diagnostic laboratories, genetic testing firms, specialty clinics, research organizations, biopharmaceutical developers, patient advocacy groups, and hospital care providers. Core applications include carrier screening, newborn or prenatal testing, rare disease diagnosis, neurological supportive care, genetic counseling, and experimental therapy development.
This product will be delivered within 1-3 business days.
Market Overview
The Tay-Sachs Disease Market covers diagnostic, supportive care, genetic counseling, and emerging therapeutic development activities focused on Tay-Sachs disease across rare disease healthcare ecosystems.Its value chain includes diagnostic laboratories, genetic testing firms, specialty clinics, research organizations, biopharmaceutical developers, patient advocacy groups, and hospital care providers. Core applications include carrier screening, newborn or prenatal testing, rare disease diagnosis, neurological supportive care, genetic counseling, and experimental therapy development.
Key Companies Analysed
- Illumina
- Thermo Fisher Scientific
- Danaher
- Roche
- Abbott
- Bio-Rad Laboratories
- PerkinElmer
- Revvity
- Agilent Technologies
- Quest Diagnostics
- Labcorp
- Natera
- Invitae
- NeoGenomics
- Bio-Techne
- Orchard Therapeutics
- Sarepta Therapeutics
- Pfizer
- Bluebird Bio
- Novartis
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Tay-Sachs Disease Market Overview
3. Tay-Sachs Disease Market Dynamics
4. Tay-Sachs Disease Market Strategic Analysis
5. Global Tay-Sachs Disease Market Size, Share and Forecast, 2025-2034
6. North America Tay-Sachs Disease Market Outlook to 2034
7. Europe Tay-Sachs Disease Market Outlook to 2034
8. Asia-Pacific Tay-Sachs Disease Market Outlook to 2034
9. Middle East and Africa Tay-Sachs Disease Market Outlook to 2034
10. South and Central America Tay-Sachs Disease Market Outlook to 2034
11. Tay-Sachs Disease Market Competitive Landscape
12. Appendix
Companies Mentioned
- Illumina
- Thermo Fisher Scientific
- Danaher
- Roche
- Abbott
- Bio-Rad Laboratories
- PerkinElmer
- Revvity
- Agilent Technologies
- Quest Diagnostics
- Labcorp
- Natera
- Invitae
- NeoGenomics
- Bio-Techne
- Orchard Therapeutics
- Sarepta Therapeutics
- Pfizer
- Bluebird Bio
- Novartis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 3.1 Billion |
| Forecasted Market Value ( USD | $ 4.9 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
